Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James B. Tananbaum

Director at Alumis Inc. (ALMS); Director at Latigo Biotherapeutics, Inc. (LTGO)

Purchase track record

Strong record. Based on 3 purchases with a full 90 days of price history.

100
Avg. 90-day return+196.2%
vs. S&P 500+195.0%
Beat the market100%
Paper profit on buys−$3.8M
Total bought / sold$13.1M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 10SEC LTGOLatigo Biotherapeutics, Inc. Buy 140,0002,008,024 held (+7%) $18.00 $2.5M -11.1%
Jan 12SEC ALMSAlumis Inc. Buy 117,6475,702,536 held (+2%) $17.00 $2.0M -57.9%
Jan 12SEC ALMSAlumis Inc. Buy 294,1172,908,332 held (+11%) $17.00 $5.0M -57.9%
Nov 25SEC ALMSAlumis Inc. Buy 72,2122,614,215 held (+3%) $7.38 $533K -3.0%
Nov 19SEC ALMSAlumis Inc. Buy 50,0002,084,129 held (+2%) $5.60 $280K +27.9%
Nov 19SEC ALMSAlumis Inc. Buy 150,0002,234,129 held (+7%) $5.59 $838K +28.1%
Nov 19SEC ALMSAlumis Inc. Buy 117,3742,351,503 held (+5%) $6.19 $727K +15.7%
Nov 19SEC ALMSAlumis Inc. Buy 190,5002,542,003 held (+8%) $6.56 $1.2M +9.1%
  • Buy

    Director James B. Tananbaum bought $2.5M of LTGO at $18.00 — first open-market purchase in our records.

  • Buy

    Director James B. Tananbaum bought $2.0M of ALMS at $17.00 — largest purchase by this insider in our records.

  • Buy

    Director James B. Tananbaum bought $5.0M of ALMS at $17.00 — largest purchase by this insider in our records.

  • Buy

    Director James B. Tananbaum bought $280K of ALMS at $5.60 — first open-market purchase in our records.

  • Buy

    Director James B. Tananbaum bought $838K of ALMS at $5.59 — largest purchase by this insider in our records.

  • Buy

    Director James B. Tananbaum bought $1.2M of ALMS at $6.56 — largest purchase by this insider in our records.